Recombinant respiratory syncytial virus vaccine(PIV5) (Guangzhou Sianxin Biotech)

重组呼吸道合胞病毒疫苗（5型副流感病毒载体）（广州思安信生物）

Report date: 2025/08/18 10:34:23

Base Information

Drug NameRecombinant respiratory syncytial virus vaccine(PIV5) (Guangzhou Sianxin Biotech)

Drug Alias Name鼻喷重组呼吸道合胞病毒疫苗（5型副流感病毒载体）

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsRespiratory Syncytial Virus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesGuangzhou Sianxin Biotechnology Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesGuangzhou Sianxin Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsRespiratory Syncytial Virus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A